Dermatitis

Papers
(The H4-Index of Dermatitis is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Long-Term Narrowband UV-B Efficacy in Moderate to Severe Atopic Dermatitis172
Environmental Dermatitis115
Association of Adult Atopic Dermatitis Severity with Bacterial, Viral, and Fungal Skin Infections42
Koebnerization from Insulin Pump and Continuous Glucose Monitor in a Patient with Psoriasis27
Systemic Treatment of Cutaneous Adverse Events after Immune Checkpoint Inhibitor Therapy: A Review21
Compositional and Functional Profile of Gut Microbiota in a Cohort of Adult Spanish Patients with Atopic Dermatitis Using Metagenomics: A Cross-Sectional Study18
Letter: Neonatal BCG Vaccination for Eczema Prevention18
Solvent Orange 60 in Tortoiseshell Spectacle Frames: The Importance of Patch Testing to This Rare Allergen18
Occupational Contact Dermatitis in Food Handlers: A 26-Year Retrospective Multicentre Study in North-East Italy (Triveneto Group on Research on Contact Dermatitis)16
Correspondence on “Efficacy, Safety, and Early Relapse after Cessation of Upadacitinib Versus Dupilumab in Adolescents With Moderate-to-Severe Atopic Dermatitis: A Real-World Study in China”15
Day 2 Patch Testing Does Not Impact Final Diagnosis in Patch Testing Process15
Recalcitrant Dyshidrotic Eczema Successfully Treated with Upadacitinib15
Pruritus and Pain Constitute the Main Negative Impact of Atopic Dermatitis® from the Patient's Perspective: A Systematic Review15
Revisiting Contact Sensitization Among Patients With LPP/FFA: Cross-Sectional Findings From 55 Cases14
Letter: Lebrikizumab for Refractory Atopic Dermatitis14
Improved Investigator Global Assessment, Allergic Contact Dermatitis-11, Dermatology Life Quality Index, and Global Quality of Life and Severity Scores after Patch Testing in Dermatitis Patients14
Letter: A Case Series Demonstrating Co-Reactivity of a Cocamidopropyl Hydroxysultaine-Containing Facial Cleanser with Dimethylamines and Amidoamine14
A Retrospective Analysis of Risk Factors for Atopic Dermatitis Severity14
0.20060992240906